TCL Archive NIH Solicits Grant applications For New Type Of Small Business Award; 40 To Be Funded September 10, 1993
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NCAB Considering Concept Review Of Large, Expensive Investigator Initiated Proposals February 16, 1990
